The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide.

Juan Pablo Robles; Magdalena Zamora; Lourdes Siqueiros-Marquez; Elva Adan-Castro; Gabriela Ramirez-Hernandez; Francisco Freinet Nuñez; Fernando Lopez-Casillas; Robert P Millar; Thomas Bertsch; Gonzalo Martínez de la Escalera; Jakob Triebel; Carmen Clapp

doi:10.1007/s10456-021-09800-x

The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide.

Juan Pablo Robles
, Magdalena Zamora (First author)
, Lourdes Siqueiros-Marquez
, Elva Adan-Castro
, Gabriela Ramirez-Hernandez
, Francisco Freinet Nuñez
, Fernando Lopez-Casillas
, Robert P Millar
, Thomas Bertsch (Co-author)
, Gonzalo Martínez de la Escalera
, Jakob Triebel (Co-author)
, Carmen Clapp

Institute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine - Central Laboratory

Research output: Contribution to journal › Original Article › peer-review

18 Citations (Web of Science)

Original language	English
Pages (from-to)	57-70
Journal	ANGIOGENESIS
Volume	25
Issue number	1
DOIs	https://doi.org/10.1007/s10456-021-09800-x
Publication status	Published - 2022

Keywords

16-KDA PROLACTIN FRAGMENT
DIABETIC-RETINOPATHY
BLOOD-VESSELS
GENE-TRANSFER
TUMOR-GROWTH
ANGIOGENESIS
PEPTIDES
INHIBITORS
ASSAY
EXPRESSION

Access to Document

10.1007/s10456-021-09800-x

Cite this

Robles, J. P., Zamora, M., Siqueiros-Marquez, L., Adan-Castro, E., Ramirez-Hernandez, G., Nuñez, F. F., Lopez-Casillas, F., Millar, R. P., Bertsch, T., Martínez de la Escalera, G., Triebel, J., & Clapp, C. (2022). The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide. ANGIOGENESIS, 25(1), 57-70. https://doi.org/10.1007/s10456-021-09800-x

@article{41be167009c44547963eea2e3143e48a,

title = "The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide.",

keywords = "16-KDA PROLACTIN FRAGMENT, DIABETIC-RETINOPATHY, BLOOD-VESSELS, GENE-TRANSFER, TUMOR-GROWTH, ANGIOGENESIS, PEPTIDES, INHIBITORS, ASSAY, EXPRESSION",

author = "Robles, \{Juan Pablo\} and Magdalena Zamora and Lourdes Siqueiros-Marquez and Elva Adan-Castro and Gabriela Ramirez-Hernandez and Nu{\~n}ez, \{Francisco Freinet\} and Fernando Lopez-Casillas and Millar, \{Robert P\} and Thomas Bertsch and \{Mart{\'i}nez de la Escalera\}, Gonzalo and Jakob Triebel and Carmen Clapp",

note = "Bertsch; Triebel: Institute for Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Nuremberg General Hospital \& Paracelsus Medical University, Nuremberg, Germany; Zamora: nein",

year = "2022",

doi = "10.1007/s10456-021-09800-x",

language = "English",

volume = "25",

pages = "57--70",

journal = "ANGIOGENESIS",

issn = "0969-6970",

publisher = "Kluwer Academic Publishers ",

number = "1",

}

Robles, JP, Zamora, M, Siqueiros-Marquez, L, Adan-Castro, E, Ramirez-Hernandez, G, Nuñez, FF, Lopez-Casillas, F, Millar, RP, Bertsch, T, Martínez de la Escalera, G, Triebel, J & Clapp, C 2022, 'The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide.', ANGIOGENESIS, vol. 25, no. 1, pp. 57-70. https://doi.org/10.1007/s10456-021-09800-x

TY - JOUR

T1 - The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide.

AU - Robles, Juan Pablo

AU - Zamora, Magdalena

AU - Siqueiros-Marquez, Lourdes

AU - Adan-Castro, Elva

AU - Ramirez-Hernandez, Gabriela

AU - Nuñez, Francisco Freinet

AU - Lopez-Casillas, Fernando

AU - Millar, Robert P

AU - Bertsch, Thomas

AU - Martínez de la Escalera, Gonzalo

AU - Triebel, Jakob

AU - Clapp, Carmen

N1 - Bertsch; Triebel: Institute for Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Nuremberg General Hospital & Paracelsus Medical University, Nuremberg, Germany; Zamora: nein

PY - 2022

Y1 - 2022

KW - 16-KDA PROLACTIN FRAGMENT

KW - DIABETIC-RETINOPATHY

KW - BLOOD-VESSELS

KW - GENE-TRANSFER

KW - TUMOR-GROWTH

KW - ANGIOGENESIS

KW - PEPTIDES

KW - INHIBITORS

KW - ASSAY

KW - EXPRESSION

U2 - 10.1007/s10456-021-09800-x

DO - 10.1007/s10456-021-09800-x

M3 - Original Article

C2 - 34097181

SN - 0969-6970

VL - 25

SP - 57

EP - 70

JO - ANGIOGENESIS

JF - ANGIOGENESIS

IS - 1

ER -